• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Stryker levels another sales rep poaching lawsuit against Zimmer Biomet

Stryker levels another sales rep poaching lawsuit against Zimmer Biomet

March 9, 2017 By Brad Perriello

Stryker, Zimmer BiometStryker (NYSE:SYK) yesterday leveled another lawsuit accusing Zimmer Biomet (NYSE:ZBH) of poaching Stryker’s roster of sales reps, this time in Texas.

Stryker in 2013 sued a pair of former sales agents, accusing them of scheming to poach reps and business from Stryker in Louisiana and New York (that case is headed to a federal appeals court, after a jury in February 2016 found for Stryker and awarded $745,195 in damages).

Yesterday, in the U.S. District Court for Southern Texas, Stryker made similar accusations, alleging a poaching scheme by Zimmer Biomet of “concerted and deliberate unfair competition, improper use of Stryker’s confidential and trade secret information, and improper solicitations of Stryker’s customers and employees” in the Houston area.

Zimmer Biomet allegedly enticed “multiple” Stryker reps to set up a rival foot & ankle business targeting Stryker customers in breach of their non-compete and non-solicitation agreements, according to the lawsuit.

The ex-reps, Andrew Ruggles and Carson Combs, “are now moving the business of those Stryker customers to defendants and utilizing Stryker confidential and trade secret information,” the lawsuit alleged.

Rugglesand Combs quit Stryker in November 2016 and allegedly recruited Combs to follow suit just 4 days later, Stryker alleged.

“Soon after the end of their respective employment at Stryker, Stryker received information that Ruggles and Combs were working together for defendant Biomet South Texas together, using joint efforts to solicit their former Stryker customers in the Houston area,” according to the lawsuit, which also alleges that other former Stryker employees are “participating in the tortious activities of defendants.”

Stryker asked Judge Gray Miller to issue a temporary restraining order and preliminary injunction barring Zimmer Biomet, Ruggles and Combs from further alleged violations, according to court documents.

Filed Under: Legal News, Orthopedics, Wall Street Beat Tagged With: Personnel Moves, Sales, Stryker, Zimmer Biomet

More recent news

  • Cognixion, Blackrock Neurotech ink distro deal for BCI tech
  • AdvaMed calls for medtech tariff exemptions at Senate hearing
  • GE HealthCare, Raydiant Oximetry partner on fetal oxygen saturation tech
  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy